These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35510040)
1. Comprehensive Analysis of Phagocytosis-Related Regulators to Aid Prognostic Prediction and Immunotherapy in Patients with Low-Grade Glioma. Li J; Huang Q; Mo L Dis Markers; 2022; 2022():4142684. PubMed ID: 35510040 [TBL] [Abstract][Full Text] [Related]
2. The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis. Hou C; Wu M; Zhang H; Yang Z Medicine (Baltimore); 2023 Mar; 102(11):e33290. PubMed ID: 36930113 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes. Ma C; Bao Y; Xu J; Xiao B; Li H J Cancer Res Clin Oncol; 2023 Jan; 149(1):47-62. PubMed ID: 36528831 [TBL] [Abstract][Full Text] [Related]
4. Radiogenomic landscape: Assessment of specific phagocytosis regulators in lower-grade gliomas. Maimaiti A; Abulaiti A; Tang B; Dilixiati Y; Li X; Yakufu S; Wang Y; Jiang L; Shao H Exp Biol Med (Maywood); 2023 Dec; 248(23):2289-2303. PubMed ID: 38062999 [TBL] [Abstract][Full Text] [Related]
5. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma. Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X Front Genet; 2022; 13():951239. PubMed ID: 36186436 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort. Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analyses and experimental validation of the role of phagocytosis in low-grade glioma. Fei M; Lu C; Feng B; Sun J; Wang J; Sun F; Dong B Environ Toxicol; 2024 Apr; 39(4):2182-2196. PubMed ID: 38112449 [TBL] [Abstract][Full Text] [Related]
9. Identification of Critical m Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046 [TBL] [Abstract][Full Text] [Related]
10. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures. Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900 [TBL] [Abstract][Full Text] [Related]
11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
12. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes. Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q Front Immunol; 2022; 13():982033. PubMed ID: 36052073 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma. Han T; Zuo Z; Qu M; Zhou Y; Li Q; Wang H Front Pharmacol; 2021; 12():748993. PubMed ID: 34712139 [No Abstract] [Full Text] [Related]
15. Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma. Zhu W; Chen Z; Fu M; Li Q; Chen X; Li X; Luo N; Tang W; Yang F; Zhang Y; Zhang Y; Peng X; Hu G Apoptosis; 2024 Feb; 29(1-2):169-190. PubMed ID: 37713112 [TBL] [Abstract][Full Text] [Related]
16. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma. Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas. Tu Z; Ji Q; Han Q; Long X; Li J; Wu L; Huang K; Zhu X BMC Cancer; 2022 Sep; 22(1):973. PubMed ID: 36096781 [TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma. Wan RJ; Peng W; Xia QX; Zhou HH; Mao XY CNS Neurosci Ther; 2021 Aug; 27(8):973-986. PubMed ID: 33969928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]